|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8560
|
|
pubmed:dateCreated |
1987-10-20
|
|
pubmed:abstractText |
Current experience with the safety and efficacy of vaccines in infected children and adults is reviewed to examine the basis for decisions about routine immunisations of children infected with the human immunodeficiency virus (HIV). No adverse reactions to inactivated vaccines have been noted, but complications with live vaccines have been recorded with both BCG and smallpox. Limited experience with live poliomyelitis and measles vaccines in HIV-infected children has not yet shown any severe complications from these vaccines. Theoretical concerns that immunisation might accelerate the course of HIV infection are not supported by available data. Serological response to most inactivated and live vaccines is reduced in HIV-infected persons, and is related to the degree of immunosuppression present. Preliminary evidence suggests that the severity of some vaccine-preventable diseases is increased in HIV-infected children. This review finds general support for recommendations on immunisation of HIV-infected children that have been developed by the World Health Organisation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria Toxoid,
http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria-Tetanus-Pertussis Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Measles Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Pertussis Vaccine,
http://linkedlifedata.com/resource/pubmed/chemical/Poliovirus Vaccine, Inactivated,
http://linkedlifedata.com/resource/pubmed/chemical/Tetanus Toxoid,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Vaccines, Attenuated
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
669-72
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2887950-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:2887950-Adult,
pubmed-meshheading:2887950-BCG Vaccine,
pubmed-meshheading:2887950-Child,
pubmed-meshheading:2887950-Diphtheria Toxoid,
pubmed-meshheading:2887950-Diphtheria-Tetanus-Pertussis Vaccine,
pubmed-meshheading:2887950-Drug Combinations,
pubmed-meshheading:2887950-Humans,
pubmed-meshheading:2887950-Immunization,
pubmed-meshheading:2887950-Infant,
pubmed-meshheading:2887950-Infant, Newborn,
pubmed-meshheading:2887950-Male,
pubmed-meshheading:2887950-Measles Vaccine,
pubmed-meshheading:2887950-Pertussis Vaccine,
pubmed-meshheading:2887950-Poliovirus Vaccine, Inactivated,
pubmed-meshheading:2887950-Risk,
pubmed-meshheading:2887950-Tetanus Toxoid,
pubmed-meshheading:2887950-Vaccines,
pubmed-meshheading:2887950-Vaccines, Attenuated
|
|
pubmed:year |
1987
|
|
pubmed:articleTitle |
Human immunodeficiency virus infection and routine childhood immunisation.
|
|
pubmed:publicationType |
Journal Article,
Review
|
